Brief Profile
Brief Profile
Please be aware that the REACH registration parts of this Brief Profile are no longer maintained; they remain frozen as of 19th May 2023. All other data parts (substance identity, C&L, key regulatory lists etc. are up to date).
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
The Brief Profile summarizes the non-confidential data on substances as it is held in the databases of the European Chemicals Agency (ECHA), including data provided by third parties. The Brief Profile is automatically generated; note that it does not currently distinguish between harmonised classification and minimum classification; information requirements under different legislative frameworks may therefore not be fully up to date or complete. For accuracy reasons, substance manufacturers and imports have the responsibility to consult official sources, e.g. the electronic edition of the Official Journal of the European Union.
This Brief Profile is covered by the ECHA Legal Notice.
Silicic acid, sodium salt
Substance Description
- EC / List name:
- IUPAC name: sodium hydroxysilanoylolate
- Substance names and other identifiers
- EC / List no.:
- 215-687-4
- CAS no.:
- 1344-09-8
- Index number:
- Molecular formula:
- HNaO3Si
- SMILES:
- [Na+].O[Si]([O-])=O
- InChI:
- InChI=1S/Na.HO3Si/c;1-4(2)3/h;1H/q+1;-1
- Type of substance:
- Mono constituent substance, UVCB
- Origin:
- Inorganic
- Registered compositions:
- 87
- Of which contain:
- 9 impurities relevant for classification
- 0 additives relevant for classification
- Substance Listed:
- EINECS (European INventory of Existing Commercial chemical Substances) List
Danger! According to the classification provided by companies to ECHA in REACH registrations this substance causes severe skin burns and eye damage, causes serious eye damage, causes skin irritation, may cause respiratory irritation and may be corrosive to metals.
Additionally, the classification provided by companies to ECHA in CLP notifications identifies that this substance is harmful if swallowed.
| Skin Irrit. 2 | H315 |
|
|
| Eye Dam. 1 | H318 |
|
|
| STOT SE 3 | H335 |
|
|
| Eye Irrit. 2 | H319 |
|
|
| Acute Tox. 4 | H302 |
|
|
| Skin Corr. 1B | H314 |
|
|
| Met. Corr. 1 | H290 |
|
|
| Not Classified |
|
||
| Skin Corr. 1A | H314 |
|
|
| Skin Corr. 1C | H314 |
|
|
| STOT SE 3 | H336 |
|
|
| Skin Corr. 1 | H314 |
|
|
| Aquatic Acute 1 | H400 |
|
|
| Aquatic Chronic 1 | H410 |
|
|
| Carc. 1B | H350 |
|
|
|
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% | ||
Harmonised Classification
REACH registration dossiers notifications
CLP notifications
At least one notifier has indicated that an impurity or an additive present in the substance impacts the notified classification.
Registration, Evaluation, Authorisation & Restriction of Chemicals (REACH)
Registration
- Pre-registration:
- Substance pre-registered under REACH.
- Registration:
- This substance has 87 active registrations under REACH, 1 Joint Submission(s) and 1 Individual Submission(s).
Evaluation
- Dossier Evaluation:
- Registration dossiers submitted to ECHA for this substance have been evaluated under REACH.
- Substance Evaluation:
Authorisation
- Candidate List:
- Annex XIV (Authorisation List):
Restriction
- Annex XVII (Restriction List):
Persistent Organic Pollutants Regulation (POPs)
- List of substances subject to the POPs Regulation:
- List of substances proposed as POPs:
Classification Labelling & Packaging (CLP)
- Harmonised C&L:
- Seveso Annex I:
- Notified C&L:
- Classification & Labelling has been notified by industry to ECHA for this substance.
Biocidal Products Regulation (BPR)
- Active Substance:
- Biocidal Products:
Prior Informed Consent (PIC)
- Annex I:
- Annex V:
European Union Observatory for Nanomaterials (EUON)
- EUON:
This substance is registered under the REACH Regulation and is manufactured in and / or imported to the European Economic Area, at ≥ 1 000 000 to < 10 000 000 tonnes per annum.
This substance is used by consumers, in articles, by professional workers (widespread uses), in formulation or re-packing, at industrial sites and in manufacturing.
This substance is used in the following products: coating products, fillers, putties, plasters, modelling clay, cosmetics and personal care products and washing & cleaning products.
Other release to the environment of this substance is likely to occur from: indoor use (e.g. machine wash liquids/detergents, automotive care products, paints and coating or adhesives, fragrances and air fresheners) and outdoor use.
This substance is used in the following activities or processes at workplace: the low energy manipulation of substances bound in materials or articles, high energy work-up of substances bound in materials or articles (e.g. hot rolling/forming, grinding, mechanical cutting, drilling or sanding), potentially closed industrial processing with minerals/metals at elevated temperature (e.g. smelters, furnaces, refineries, coke ovens) and open transfer and processing with minerals/metals at elevated temperature.
Other release to the environment of this substance is likely to occur from: indoor use in long-life materials with low release rate (e.g. flooring, furniture, toys, construction materials, curtains, foot-wear, leather products, paper and cardboard products, electronic equipment), outdoor use in long-life materials with low release rate (e.g. metal, wooden and plastic construction and building materials), outdoor use in long-life materials with high release rate (e.g. tyres, treated wooden products, treated textile and fabric, brake pads in trucks or cars, sanding of buildings (bridges, facades) or vehicles (ships)) and indoor use in long-life materials with high release rate (e.g. release from fabrics, textiles during washing, removal of indoor paints).
This substance can be found in complex articles, with no release intended: vehicles and machinery, mechanical appliances and electrical/electronic products (e.g. computers, cameras, lamps, refrigerators, washing machines). This substance can be found in products with material based on: fabrics, textiles and apparel (e.g. clothing, mattress, curtains or carpets, textile toys) and leather (e.g. gloves, shoes, purses, furniture). This substance is intended to be released from scented: clothes.
This substance is used in the following products: coating products, washing & cleaning products, water treatment chemicals and cosmetics and personal care products.
This substance is used in the following areas: mining, building & construction work, health services, municipal supply (e.g. electricity, steam, gas, water) and sewage treatment, agriculture, forestry and fishing and printing and recorded media reproduction. This substance is used for the manufacture of: mineral products (e.g. plasters, cement), fabricated metal products, food products, pulp, paper and paper products and metals.
This substance is used in the following activities or processes at workplace: transfer of chemicals, hand mixing with intimate contact only with personal protective equipment available and roller or brushing applications.
Release to the environment of this substance can occur from industrial use: in processing aids at industrial sites. Other release to the environment of this substance is likely to occur from: indoor use (e.g. machine wash liquids/detergents, automotive care products, paints and coating or adhesives, fragrances and air fresheners), outdoor use and indoor use in close systems with minimal release (e.g. cooling liquids in refrigerators, oil-based electric heaters).
This substance is used in the following products: adhesives and sealants and textile treatment products and dyes.
This substance is used in the following activities or processes at workplace: transfer of chemicals, mixing in open batch processes, batch processing in synthesis or formulation with opportunity for exposure, closed, continuous processes with occasional controlled exposure, industrial spraying and closed batch processing in synthesis or formulation.
Release to the environment of this substance can occur from industrial use: formulation in materials, in the production of articles, formulation of mixtures and as processing aid.
This substance is used in the following products: adhesives and sealants, coating products, pH regulators and water treatment products, welding & soldering products and textile treatment products and dyes.
This substance is used in the following areas: building & construction work, mining and formulation of mixtures and/or re-packaging. This substance is used for the manufacture of: mineral products (e.g. plasters, cement) and furniture.
This substance is used in the following activities or processes at workplace: transfer of chemicals, mixing in open batch processes, batch processing in synthesis or formulation with opportunity for exposure, industrial spraying, roller or brushing applications and closed, continuous processes with occasional controlled exposure.
Release to the environment of this substance can occur from industrial use: in the production of articles, formulation in materials, in processing aids at industrial sites and as processing aid. Other release to the environment of this substance is likely to occur from: indoor use (e.g. machine wash liquids/detergents, automotive care products, paints and coating or adhesives, fragrances and air fresheners) and outdoor use.
This substance is used in the following activities or processes at workplace: transfer of chemicals, closed, continuous processes with occasional controlled exposure, transfer of substance into small containers, batch processing in synthesis or formulation with opportunity for exposure and industrial spraying.
Release to the environment of this substance can occur from industrial use: manufacturing of the substance, formulation of mixtures and as an intermediate step in further manufacturing of another substance (use of intermediates).
Precautions for using this substance have been recommended by its registrants under REACH, as follows:
Prevention statements
When handling this substance: avoid breathing the dust, fume, gas, mist, vapours or spray; do not get in eyes, on skin, or on clothing; wear protective gloves and/or clothing, and eye and/or face protection as specified by manufacturer/supplier.
Response statements
In case of incident: If on skin (or hair): take off immediately all contaminated clothing. Rinse skin with water or shower. If swallowed: rinse mouth. Do not induce vomiting. Wash contaminated clothing before reuse. Immediately call a poison center or doctor/physician. If in eyes: rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do – continue rinsing.
Guidance on the safe use of the substance provided by manufacturers and importers of this substance.
- AB Lindec, Box 5 42121 Västra Frölunda Sweden
- ACRILATOS S.A.U, Avda. Extremadura, s/n. Pol. Ind. El Colomer 12200 Onda Castellón Spain
- Alcochem Minerals BV, Zeilmaker 4 3861 SM Nijkerk (Gld.) Netherlands
- Arcillas Refractarias, S. A., Barrio Castiello, s/n 33690 Lugo de Llanera Asturias Spain
- B-Lands Consulting (811375-9), World Trade Center, 5 Place Robert Schuman - BP 1516 38025 Grenoble France France
- BASF Personal Care and Nutrition GmbH, Henkelstr. 67 40589 Düsseldorf Germany
- BASF SE, Carl-Bosch-Str. 38 67056 Ludwigshafen am Rhein Rheinland-Pfalz Germany
- BENS consulting d.o.o., Bakovniška 7 1241 Kamnik Slovenia
- CHEMICAL INSPECTION & REGULATION SERVICE LIMITED, Regus Harcourt Centre D02 HW77 Dublin Ireland
- Chemreach GmbH, Akazienweg 30 48317 Drensteinfurt Germany
- Chemservice GmbH - (L4T9), Herrnsheimer Hauptstrasse 1b 67550 Worms Germany
- CIECH Soda Romania, 2, Uzinei Street 240050 Ramnicu Valcea Valcea Romania
- Ciech Vitrosilicon SA, Zaganska 27 68120 Ilowa Poland
- Colgate-Palmolive Services (Poland) sp. z o.o. / OR Guatemala, ul. Tasmowa 7 02-677 Warsaw Poland
- Colorobbia España, S.A., CV-160 Km. 16,3 12192 Villafames Castellón Spain
- Crosfield Italia srl, Via dei Cipressi, 10 37141 Verona Italy
- DEKRA Assurance Services GmbH OR07, Handwerkstr. 15 70565 Stuttgart Germany
- Detergenti S.A., Mihai Viteazu street no. 1, Prahova county 106300 Urlati Romania
- Dow Silicones Belgium SPRL OR-1, rue Jules Bordet Parc industriel C 7180 Seneffe Belgium
- Dow Silicones Belgium SPRL OR-2, Rue Jules Bordet Parc industriel C 7180 Seneffe Belgium
- Dow Silicones Belgium SPRL OR-5, Rue Jules Bordet Zone industrielle C 7180 Seneffe Belgium
- Ecolab Production Belgium B.V.B.A., Havenlaan 4 3980 Tessenderlo Belgium
- EcoMole s.r.o, U Větrníku 40/1 16200 Praha 6-Břevnov Czech Republic
- Ege Italia s.r.l., Viale Verdi 88/b 23807 Merate 23807 Lecco Italy Italy
- Evonik Operations GmbH, Rellinghauser Straße 1-11 45128 Essen Germany
- Evonik Silica Finland Oy, Telakkatie 5 49460 Hamina Finland
- Evonik Silquimica S.A., Ctra. Miranda de Ebro a Puentelarrá, Km 5 01213 Zubillage-Lantarón (Alava) Spain
- Ferro France S.A.R.L., 43 rue Jeanne d'Arc 52115 Saint-Dizier Cedex France
- Fosbel GmbH, Karstrasse 116 41068 Mönchengladbach Germany
- GRACE Silica GmbH, Kreuzauer Str. 46 52355 Düren Germany
- Hayat Bulgaria Chemical LTD, acting as “only representative” in the European Union (EU) for Hayat Kimya Sanayi A.S. Turkey" , Zapadna promishlena zona 9000 Varna Bulgaria
- Henkel Global Supply Chain B.V., Gustav Mahlerlaan 2970 1081 LA Amsterdam Netherlands
- Industria Chimica Vera SpA, Via don Luigi Repetti 89/93 20027 Rescaldina Italy
- Industrias Quimicas del Ebro, Poligono Malpica Calle D 97 50016 Zaragoza Spain
- INGESSIL S.r.l., via dei Peschi, 13 37141 Montorio di Verona Italy
- Innospec Performance Chemicals France SAS (Only Rep 4), Boite Postale 19 Han-sur-Meuse F-55300 St. Mihiel Meuse France
- INTERTEK FRANCE, ZAC Ecoparc II 27400 HEUDEBOUVILLE France
- ITW Performance Polymers, A Division of ITW Ireland, Bay 150 Shannon Industrial Estate V14 DF82 Shannon Co. Clare Ireland
- Lincoln Electric Europe B.V., Nieuwe Dukenburgseweg 20 6534 AD Nijmegen Netherlands
- LINCOLN ELECTRIC ITALIA S.r.l., Loc. Casalmenini, 3 37010 Rivoli Veronese VR Italy
- MAGNIFIN Magnesiapodukte GmbH & Co KG, Magnesitstrasse 40 8614 Breitenau am Hochlantsch Austria
- Momentive Performance Materials GmbH, Chempark, Building V7 PO 4502311119 51368 Leverkusen NRW Germany
- Nalco Europe B.V., Oude Rhijnhofweg 17 2342 BB Oegstgeest Netherlands
- NEOCHIMIKI SA, PENTELIS 34 175 64 P.FALIRO ATHENS Greece
- NOVABION, 13 rue du crochet 02310 NOGENT L'ARTAUD France
- OLEOCHEM, a.s., Žukovova 49/30 40003 Ústí nad Labem Czech Republic
- Only representative (No publishable name), null
- Penetron Hellas S.A., 50 Thrakomakedonon Av. 13679 Acharnes Attiki Greece
- PQ France SAS, Usine de Lamotte BP 30 60350 Trosly-Breuil France
- PQ Germany GmbH, Am Wachtelberg 8a 04808 Wurzen Germany
- PQ Silicas BV, Ir. Rocourstraat 28 6245 AD Eijsden Netherlands
- PQ Silicas BV - OR1, Ir. Rocourstraat 28 6245 AD Eijsden Netherlands
- PQ Silicas BV - OR10, Ir. Rocourstraat 28 6245 AD Eijsden Netherlands
- PQ Silicas BV - OR4, Ir. Rocourstraat 28 6245 AD Eijsden Netherlands
- PQ Silicas BV - OR7, Ir. Rocourstraat 28 6245 AD Eijsden Netherlands
- PRAYON S.A., 144, rue Joseph Wauters 4480 ENGIS Belgium
- PROCHIN ITALIA PRODOTTI CHIMICI INDUSTRIALI SRL, ASI SUD 81025 MARCIANISE CASERTA Italy
- Procter & Gamble – Rakona s.r.o., Ottova 402 269 32 Rakovnik Czech Republic
- PRODUCTOS CAPILARES L'OREAL S.A., Calle Lopez Bravo n°78 Poligono Industrial Villalonquéjar 09001 BURGOS Spain
- Quimialmel - Químicos e Minerais, Lda., Estrada Nacional nº 1 Apartado 150 3850-200 ALBERGARIA-A-VELHA Portugal
- REACH MONITOR SLU , Carrer Orient 78-84 5è, 2a 08072 Sant Cugat del Vallès Spain
- REACH NATION 12, 22 Rue Notre Dame au Bois 1440 Braine-le-Château Walloon Brabant Belgium
- REACH NATION 23, 22 Rue Notre Dame au Bois 1440 Braine-le-Château Walloon Brabant Belgium
- REACH24H CONSULTING GROUP, reach@reach24h.com Dublin18 Dublin Ireland
- REACH24H CONSULTING GROUP, Paramount Court, Corrig Road, Sandyford Dublin18 Dublin Ireland
- REACHLaw Ltd., Aleksanterinkatu 19 00100 Helsinki Finland
- REGARTIS s.r.o, Rubeška 393/7 19000 Prague Czech Republic
- Regenesis Bioremediation Products Ltd, F8 Nutgrove Office Park Rathfarnham D14 K1C24 Dublin Ireland
- RHODIA OPERATIONS, 9 rue des Cuirassiers Immeuble Silex 2 Solvay 69003 LYON France
- SC29 Sinak Corporation, Długosza 67 43-188 Orzesze Poland
- SEPR, BP 60025 Route de Lyon 84131 le pontet cedex France
- Shin-Etsu Silicones Europe BV - Importer, Bolderweg 32 1332 AV Almere Netherlands
- SILICATOS DE MALPICA S.L, Polígono La Cruz P-1-3 48170 Zamudio Vizcaya Spain
- SILKEM, d.o.o., Tovarniška cesta 10 2325 Kidričevo Slovenia Slovenia
- SILMACO NV, Industrieweg 90 3620 Lanaken Belgium
- Skystep Trading Limited, Leda Court, OFF 102A, 23A Spetson str., Mesa Geitonia 4000 Limassol Cyprus
- Solvay Solutions Italia S.p.A., Via Milano, 78/80 20021 Ospiate di Bollate (Mi) Italy
- Specialty Electronic Materials Belgium SRL OR-1, Boulevard d’Angleterre 2 1420 Braine-l’Alleud Belgium
- Spetsinterproject Oy, Näkinkaari 1 M 02320 Espoo Finland
- Toyota Tsusho Europe S.A., Belgicastraat 13 1930 Zaventem Belgium
- Vetra Srl, Via Larga 31 20122 Milan Italy
- Vodní sklo, a.s., Krakovská 1346/15 11001 Praha 1 Czech Republic
- Wöllner GmbH, Wöllnerstraße 26 67065 Ludwigshafen Rheinland-Pfalz Germany
- Zaklady Chemiczne "Rudniki" S.A., Fabryczna 1 42-240 Rudniki Poland
- ZANGAS Hoch-und Tiefbau GmbH, Schwindgasse 5/1/4 1040 Vienna Austria
- Zeolitas de Álava s.l., Avenida Diagonal 530-532, 3ª planta 08006 Barcelona Spain
- ZSCHIMMER & SCHWARZ ESPAÑA ,S.L.U, Ctra. CV-20 KM 3,200 12540 Villarreal, Castellón Spain
- Chemours Netherlands B.V., Baanhoekweg 22 3313 LA Dordrecht Netherlands
- Chemours Netherlands B.V._1, Baanhoekweg 22 3313 LA Dordrecht Netherlands
- Chemours Netherlands B.V._4, Baanhoekweg 22 3313 LA Dordrecht Netherlands
- Chemours Netherlands B.V._5, Baanhoekweg 22 3313 LA Dordrecht Netherlands
- Evonik Peroxide Spain s.l.u., Afueras s/n 50784 La Zaida Zaragoza Spain
- HyChem – Química Sustentável, S.A, RUA ENG. CLEMENT DUMOULIN 2625-106 POVOA DE SANTA IRIA Portugal
- momaja s.r.o., Karolinska 650/1 186 00 Prague 8 Czech Republic
- momaja s.r.o., Karolinská 650/1 186-00 Prague 8 Czech Republic
- momaja s.r.o., Karolinská 650/1 - 186-00 Prague 8 Czech Republic
- SOCIETA' CHIMICA BUSSI S.P.A., Piazzale Elettrochimica 1 65022 Bussi sul Tirino Italy
- Unilever Nederlands Services BV 04, Weena 455 3013 AL Rotterdam Netherlands
- VENATOR MATERIALS UK LIMITED - OR2, Titanium House Hanzard Drive TS22 5FD Wynyard Park United Kingdom
- Zeolite Mira Srl Unipersonale, Via Sant' Antonio 5 30034 Mira Venice Italy
Scientific properties
This section provides physicochemical information compiled from all automatically processable data from REACH registration dossiers that is available to ECHA at the time of generation. The quality and correctness of the information remains the responsibility of the data submitter. The Agency thus cannot guarantee the correctness of the information displayed.
Study results
- 3 studies submitted
- 1 study processed
- C Physical state at 20°C and 1013 hPa
- Solid (100%) [1]
- C Form
- Compact (100%) [1]
- C Odour
- Other (100%) [1]
- C Substance type
- Inorganic (100%) [1]
Type of Study provided
| Studies with data | ||||
|---|---|---|---|---|
| Key study | 2 | |||
| Supporting study | ||||
| Weight of evidence | ||||
| Other | 1 |
| Data waiving | |
|---|---|
| no waivers | |
C Summaries
- 1 summary submitted
- 1 summary processed
- Physical state at 20°C and 1013 hPa
- Solid (100%)
Study results
- 7 studies submitted
- 1 study processed
- R Melting / freezing point
- 730 - 870 °C [1]
Type of Study provided
| Studies with data | ||||
|---|---|---|---|---|
| Key study | 2 | |||
| Supporting study | ||||
| Weight of evidence | ||||
| Other | 5 |
| Data waiving | |
|---|---|
| no waivers | |
Summaries
- 2 summaries submitted
- 0 summaries processed
No automatically processable data submitted
Study results
- 3 studies submitted
- 0 studies processed
No automatically processable data submitted
Type of Study provided
| Studies with data | ||||
|---|---|---|---|---|
| Key study | ||||
| Supporting study | ||||
| Weight of evidence | ||||
| Other | 1 |
| Data waiving | |
|---|---|
| Not feasible | |
| Sci. unjustified | 2 |
| Exposure cons. | |
| Other |
Summaries
- 1 summary submitted
- 0 summaries processed
No automatically processable data submitted
Study results
- 13 studies submitted
- 1 study processed
- R Density
- 1.26 - 1.71 g/cm³ @ 20 °C [1]
Type of Study provided
| Studies with data | ||||
|---|---|---|---|---|
| Key study | ||||
| Supporting study | ||||
| Weight of evidence | 12 | |||
| Other | 1 |
| Data waiving | |
|---|---|
| no waivers | |
Summaries
- 2 summaries submitted
- 0 summaries processed
No automatically processable data submitted
Study results
- 5 studies submitted
- 3 studies processed
- R Vapour pressure
- 0.16 - 0.31 Pa @ 1 165 - 1 172 °C [3]
Type of Study provided
| Studies with data | ||||
|---|---|---|---|---|
| Key study | 3 | |||
| Supporting study | 1 | |||
| Weight of evidence | ||||
| Other | 1 |
| Data waiving | |
|---|---|
| no waivers | |
Summaries
- 2 summaries submitted
- 0 summaries processed
No automatically processable data submitted
Study results
- 2 studies submitted
- 0 studies processed
No automatically processable data submitted
Type of Study provided
| Studies with data | ||||
|---|---|---|---|---|
| Key study | ||||
| Supporting study | ||||
| Weight of evidence | ||||
| Other |
| Data waiving | |
|---|---|
| Not feasible | |
| Sci. unjustified | 2 |
| Exposure cons. | |
| Other |
Summaries
- 1 summary submitted
- 0 summaries processed
No automatically processable data submitted
Study results
- 13 studies submitted
- 2 studies processed
- R Water solubility (mass/vol.)
- 115 mg/L @ 25 °C and pH 7 [2]
Type of Study provided
| Studies with data | ||||
|---|---|---|---|---|
| Key study | ||||
| Supporting study | ||||
| Weight of evidence | 2 | 6 | ||
| Other | 5 |
| Data waiving | |
|---|---|
| no waivers | |
R Summaries
- 2 summaries submitted
- 1 summary processed
- Water solubility
- 115 mg/L @ 25 °C
Study results
- 2 studies submitted
- 0 studies processed
No automatically processable data submitted
Type of Study provided
| Studies with data | ||||
|---|---|---|---|---|
| Key study | ||||
| Supporting study | ||||
| Weight of evidence | ||||
| Other |
| Data waiving | |
|---|---|
| Not feasible | |
| Sci. unjustified | 2 |
| Exposure cons. | |
| Other |
Summaries
- 1 summary submitted
- 0 summaries processed
No automatically processable data submitted
Study results
- 2 studies submitted
- 0 studies processed
No automatically processable data submitted
Type of Study provided
| Studies with data | ||||
|---|---|---|---|---|
| Key study | ||||
| Supporting study | ||||
| Weight of evidence | ||||
| Other |
| Data waiving | |
|---|---|
| Not feasible | |
| Sci. unjustified | 2 |
| Exposure cons. | |
| Other |
Summaries
- 1 summary submitted
- 0 summaries processed
No automatically processable data submitted
Study results
- 3 studies submitted
- 0 studies processed
No automatically processable data submitted
Type of Study provided
| Studies with data | ||||
|---|---|---|---|---|
| Key study | ||||
| Supporting study | ||||
| Weight of evidence | ||||
| Other | 1 |
| Data waiving | |
|---|---|
| Not feasible | |
| Sci. unjustified | 2 |
| Exposure cons. | |
| Other |
Summaries
- 1 summary submitted
- 0 summaries processed
No automatically processable data submitted
Study results
- 2 studies submitted
- 0 studies processed
No automatically processable data submitted
Type of Study provided
| Studies with data | ||||
|---|---|---|---|---|
| Key study | ||||
| Supporting study | ||||
| Weight of evidence | ||||
| Other |
| Data waiving | |
|---|---|
| Not feasible | |
| Sci. unjustified | 2 |
| Exposure cons. | |
| Other |
Summaries
- 1 summary submitted
- 0 summaries processed
No automatically processable data submitted
Study results
- 5 studies submitted
- 0 studies processed
No automatically processable data submitted
Type of Study provided
| Studies with data | ||||
|---|---|---|---|---|
| Key study | ||||
| Supporting study | ||||
| Weight of evidence | ||||
| Other |
| Data waiving | |
|---|---|
| Not feasible | |
| Sci. unjustified | 5 |
| Exposure cons. | |
| Other |
C Summaries
- 1 summary submitted
- 1 summary processed
- Flammability
- Not classified (100%)
Study results
- 2 studies submitted
- 0 studies processed
No automatically processable data submitted
Type of Study provided
| Studies with data | ||||
|---|---|---|---|---|
| Key study | ||||
| Supporting study | ||||
| Weight of evidence | ||||
| Other |
| Data waiving | |
|---|---|
| Not feasible | |
| Sci. unjustified | 2 |
| Exposure cons. | |
| Other |
C Summaries
- 1 summary submitted
- 1 summary processed
- Explosiveness
- Non-explosive (100%)
Study results
- 2 studies submitted
- 0 studies processed
No automatically processable data submitted
Type of Study provided
| Studies with data | ||||
|---|---|---|---|---|
| Key study | ||||
| Supporting study | ||||
| Weight of evidence | ||||
| Other |
| Data waiving | |
|---|---|
| Not feasible | |
| Sci. unjustified | 2 |
| Exposure cons. | |
| Other |
C Summaries
- 1 summary submitted
- 1 summary processed
- Oxidising
- Non oxidising (100%)
Study results
- 1 study submitted
- 0 studies processed
No automatically processable data submitted
Type of Study provided
| Studies with data | ||||
|---|---|---|---|---|
| Key study | ||||
| Supporting study | ||||
| Weight of evidence | ||||
| Other | 1 |
| Data waiving | |
|---|---|
| no waivers | |
No summary exists for this scientific endpoint
Study results
- 2 studies submitted
- 2 studies processed
- C Dissociating properties
- Yes (100%) [2]
- R Dissociation constant
- 9.9 - 12 @ 30 °C [2]
Type of Study provided
| Studies with data | ||||
|---|---|---|---|---|
| Key study | 2 | |||
| Supporting study | ||||
| Weight of evidence | ||||
| Other |
| Data waiving | |
|---|---|
| no waivers | |
Summaries
- 2 summaries submitted
- 0 summaries processed
No automatically processable data submitted
Study results
- 6 studies submitted
- 0 studies processed
No automatically processable data submitted
Type of Study provided
| Studies with data | ||||
|---|---|---|---|---|
| Key study | ||||
| Supporting study | ||||
| Weight of evidence | ||||
| Other | 4 |
| Data waiving | |
|---|---|
| Not feasible | |
| Sci. unjustified | 2 |
| Exposure cons. | |
| Other |
Summaries
- 1 summary submitted
- 0 summaries processed
No automatically processable data submitted
This section provides environmental fate and pathways information compiled from all automatically processable data from REACH registration dossiers that is available to ECHA at the time of generation. The quality and correctness of the information remains the responsibility of the data submitter. The Agency thus cannot guarantee the correctness of the information displayed.
Study results
- 2 studies submitted
- 0 studies processed
No automatically processable data submitted
Type of Study provided
| Studies with data | ||||
|---|---|---|---|---|
| Key study | ||||
| Supporting study | ||||
| Weight of evidence | ||||
| Other |
| Data waiving | |
|---|---|
| Not feasible | |
| Sci. unjustified | 2 |
| Exposure cons. | |
| Other |
Summaries
- 2 summaries submitted
- 0 summaries processed
No automatically processable data submitted
Study results
- 2 studies submitted
- 0 studies processed
Study data not processed for brief profile
Type of Study provided
| Studies with data | ||||
|---|---|---|---|---|
| Key study | 2 | |||
| Supporting study | ||||
| Weight of evidence | ||||
| Other |
| Data waiving | |
|---|---|
| no waivers | |
Summaries
- 2 summaries submitted
- 0 summaries processed
No automatically processable data submitted
Study results
- 2 studies submitted
- 0 studies processed
No automatically processable data submitted
Type of Study provided
| Studies with data | ||||
|---|---|---|---|---|
| Key study | ||||
| Supporting study | ||||
| Weight of evidence | ||||
| Other |
| Data waiving | |
|---|---|
| Not feasible | |
| Sci. unjustified | 2 |
| Exposure cons. | |
| Other |
Summaries
- 2 summaries submitted
- 0 summaries processed
No automatically processable data submitted
Study results
- 2 studies submitted
- 0 studies processed
No automatically processable data submitted
Type of Study provided
| Studies with data | ||||
|---|---|---|---|---|
| Key study | ||||
| Supporting study | ||||
| Weight of evidence | ||||
| Other |
| Data waiving | |
|---|---|
| Not feasible | |
| Sci. unjustified | 2 |
| Exposure cons. | |
| Other |
Summaries
- 2 summaries submitted
- 0 summaries processed
No automatically processable data submitted
Study results
- 6 studies submitted
- 0 studies processed
No automatically processable data submitted
Type of Study provided
| Studies with data | ||||
|---|---|---|---|---|
| Key study | ||||
| Supporting study | ||||
| Weight of evidence | ||||
| Other | 2 | 1 |
| Data waiving | |
|---|---|
| Not feasible | |
| Sci. unjustified | 3 |
| Exposure cons. | |
| Other |
Summaries
- 2 summaries submitted
- 0 summaries processed
No automatically processable data submitted
Study results
- 0 studies submitted
- 0 studies processed
Study data not processed for brief profile
Type of Study provided
| Studies with data | ||||
|---|---|---|---|---|
| Key study | ||||
| Supporting study | ||||
| Weight of evidence | ||||
| Other |
| Data waiving | |
|---|---|
| no waivers | |
Summaries
- 2 summaries submitted
- 0 summaries processed
No automatically processable data submitted
Study results
- 2 studies submitted
- 0 studies processed
Study data not processed for brief profile
Type of Study provided
| Studies with data | ||||
|---|---|---|---|---|
| Key study | ||||
| Supporting study | ||||
| Weight of evidence | ||||
| Other |
| Data waiving | |
|---|---|
| Not feasible | |
| Sci. unjustified | 2 |
| Exposure cons. | |
| Other |
Summaries
- 2 summaries submitted
- 0 summaries processed
No automatically processable data submitted
Study results
- 4 studies submitted
- 0 studies processed
Study data not processed for brief profile
Type of Study provided
| Studies with data | ||||
|---|---|---|---|---|
| Key study | 2 | |||
| Supporting study | ||||
| Weight of evidence | ||||
| Other | 2 |
| Data waiving | |
|---|---|
| no waivers | |
Summaries
- 2 summaries submitted
- 0 summaries processed
No automatically processable data submitted
Study results
- 2 studies submitted
- 0 studies processed
No automatically processable data submitted
Type of Study provided
| Studies with data | ||||
|---|---|---|---|---|
| Key study | ||||
| Supporting study | ||||
| Weight of evidence | ||||
| Other |
| Data waiving | |
|---|---|
| Not feasible | |
| Sci. unjustified | 2 |
| Exposure cons. | |
| Other |
Summaries
- 2 summaries submitted
- 0 summaries processed
No automatically processable data submitted
Study results
- 2 studies submitted
- 0 studies processed
No automatically processable data submitted
Type of Study provided
| Studies with data | ||||
|---|---|---|---|---|
| Key study | ||||
| Supporting study | ||||
| Weight of evidence | ||||
| Other |
| Data waiving | |
|---|---|
| Not feasible | |
| Sci. unjustified | 2 |
| Exposure cons. | |
| Other |
Summaries
- 2 summaries submitted
- 0 summaries processed
No automatically processable data submitted
Study results
- 2 studies submitted
- 0 studies processed
No automatically processable data submitted
Type of Study provided
| Studies with data | ||||
|---|---|---|---|---|
| Key study | ||||
| Supporting study | ||||
| Weight of evidence | ||||
| Other |
| Data waiving | |
|---|---|
| Not feasible | |
| Sci. unjustified | 2 |
| Exposure cons. | |
| Other |
No summary exists for this scientific endpoint
This section provides ecotoxicological information compiled from all automatically processable data from REACH registration dossiers that is available to ECHA at the time of generation. The quality and correctness of the information remains the responsibility of the data submitter. The Agency thus cannot guarantee the correctness of the information displayed.
R Summaries
- 2 summaries submitted
- 2 summaries processed
The Predicted No-Effect Concentration (PNEC) value is the concentration of a substance below which adverse effects in the environment are not expected to occur. Please note that when more than one summary is provided, PNEC values may refer to constituents of the substance and not to the substance as a whole. More detailed information is available in the dossiers.
| Hazard for Aquatic Organisms | |
|---|---|
| Freshwater | 7.5 mg/L (2) |
| Intermittent releases (freshwater) | 7.5 mg/L (2) |
| Marine water | 1 mg/L (2) |
| Intermittent releases (marine water) | - |
| Sewage treatment plant (STP) | 348 mg/L (2) |
| Sediment (freshwater) | No hazard identified (1) |
| Sediment (marine water) | No hazard identified (1) |
| Hazard for Air | |
|---|---|
| Air | No hazard identified (1) |
| Hazard for Terrestrial Organism | |
| Soil | No hazard identified (1) |
| Hazard for Predators | |
| Secondary poisoning | No potential for bioaccumulation (1) |
Study results
- 7 studies submitted
- 4 studies processed
- P/RResults
- LC50 (4 days) 260 - 1 108 mg/L [4]
- LC100 (4 days) 1.949 g/L [2]
- NOEC (4 days) 348 mg/L [2]
Type of Study provided
| Studies with data | ||||
|---|---|---|---|---|
| Key study | 4 | |||
| Supporting study | ||||
| Weight of evidence | ||||
| Other | 2 | 1 |
| Data waiving | |
|---|---|
| no waivers | |
Summaries
- 2 summaries submitted
- 0 summaries processed
No automatically processable data submitted
Study results
- 2 studies submitted
- 0 studies processed
No automatically processable data submitted
Type of Study provided
| Studies with data | ||||
|---|---|---|---|---|
| Key study | ||||
| Supporting study | ||||
| Weight of evidence | ||||
| Other |
| Data waiving | |
|---|---|
| Not feasible | |
| Sci. unjustified | 2 |
| Exposure cons. | |
| Other |
Summaries
- 2 summaries submitted
- 0 summaries processed
No automatically processable data submitted
Study results
- 11 studies submitted
- 2 studies processed
- P/RResults
- EC50 (48 h) 1.7 g/L [2]
- EC0 (48 h) 100 mg/L [2]
- EC100 (48 h) 10 g/L [2]
Type of Study provided
| Studies with data | ||||
|---|---|---|---|---|
| Key study | 2 | |||
| Supporting study | ||||
| Weight of evidence | ||||
| Other | 6 | 3 |
| Data waiving | |
|---|---|
| no waivers | |
Summaries
- 2 summaries submitted
- 0 summaries processed
No automatically processable data submitted
Study results
- 2 studies submitted
- 0 studies processed
No automatically processable data submitted
Type of Study provided
| Studies with data | ||||
|---|---|---|---|---|
| Key study | ||||
| Supporting study | ||||
| Weight of evidence | ||||
| Other |
| Data waiving | |
|---|---|
| Not feasible | |
| Sci. unjustified | 2 |
| Exposure cons. | |
| Other |
Summaries
- 2 summaries submitted
- 0 summaries processed
No automatically processable data submitted
Study results
- 2 studies submitted
- 2 studies processed
- P/RResults
- EC50 (72 h) 207 - 345.4 mg/L [4]
- EC0 (72 h) 35 mg/L [2]
Type of Study provided
| Studies with data | ||||
|---|---|---|---|---|
| Key study | 2 | |||
| Supporting study | ||||
| Weight of evidence | ||||
| Other |
| Data waiving | |
|---|---|
| no waivers | |
Summaries
- 2 summaries submitted
- 0 summaries processed
No automatically processable data submitted
Study results
- 6 studies submitted
- 4 studies processed
- P/RResults
- EC0 (18 h) 348 - 3 480 mg/L [4]
- EC0 (30 min) 3.454 g/L [2]
Type of Study provided
| Studies with data | ||||
|---|---|---|---|---|
| Key study | 4 | |||
| Supporting study | ||||
| Weight of evidence | ||||
| Other | 2 |
| Data waiving | |
|---|---|
| no waivers | |
Summaries
- 2 summaries submitted
- 0 summaries processed
No automatically processable data submitted
Study results
- 2 studies submitted
- 0 studies processed
No automatically processable data submitted
Type of Study provided
| Studies with data | ||||
|---|---|---|---|---|
| Key study | ||||
| Supporting study | ||||
| Weight of evidence | ||||
| Other |
| Data waiving | |
|---|---|
| Not feasible | |
| Sci. unjustified | 2 |
| Exposure cons. | |
| Other |
Summaries
- 2 summaries submitted
- 0 summaries processed
No automatically processable data submitted
Study results
- 2 studies submitted
- 0 studies processed
No automatically processable data submitted
Type of Study provided
| Studies with data | ||||
|---|---|---|---|---|
| Key study | ||||
| Supporting study | ||||
| Weight of evidence | ||||
| Other |
| Data waiving | |
|---|---|
| Not feasible | |
| Sci. unjustified | 2 |
| Exposure cons. | |
| Other |
Summaries
- 2 summaries submitted
- 0 summaries processed
No automatically processable data submitted
Study results
- 3 studies submitted
- 2 studies processed
- P/RResults
- LD0 (48 h) 25 µg per animal [2]
- LD50 (48 h) 25 µg per animal [2]
Type of Study provided
| Studies with data | ||||
|---|---|---|---|---|
| Key study | 1 | 1 | 1 | |
| Supporting study | ||||
| Weight of evidence | ||||
| Other |
| Data waiving | |
|---|---|
| no waivers | |
Summaries
- 2 summaries submitted
- 0 summaries processed
No automatically processable data submitted
Study results
- 2 studies submitted
- 0 studies processed
No automatically processable data submitted
Type of Study provided
| Studies with data | ||||
|---|---|---|---|---|
| Key study | ||||
| Supporting study | ||||
| Weight of evidence | ||||
| Other |
| Data waiving | |
|---|---|
| Not feasible | |
| Sci. unjustified | 2 |
| Exposure cons. | |
| Other |
Summaries
- 2 summaries submitted
- 0 summaries processed
No automatically processable data submitted
Study results
- 2 studies submitted
- 0 studies processed
No automatically processable data submitted
Type of Study provided
| Studies with data | ||||
|---|---|---|---|---|
| Key study | ||||
| Supporting study | ||||
| Weight of evidence | ||||
| Other |
| Data waiving | |
|---|---|
| Not feasible | |
| Sci. unjustified | 2 |
| Exposure cons. | |
| Other |
Summaries
- 2 summaries submitted
- 0 summaries processed
No automatically processable data submitted
Study results
- 2 studies submitted
- 0 studies processed
No automatically processable data submitted
Type of Study provided
| Studies with data | ||||
|---|---|---|---|---|
| Key study | ||||
| Supporting study | ||||
| Weight of evidence | ||||
| Other |
| Data waiving | |
|---|---|
| Not feasible | |
| Sci. unjustified | 2 |
| Exposure cons. | |
| Other |
Summaries
- 2 summaries submitted
- 0 summaries processed
No automatically processable data submitted
This section provides toxicological information compiled from all automatically processable data from REACH registration dossiers that is available to ECHA at the time of generation. The quality and correctness of the information remains the responsibility of the data submitter. The Agency thus cannot guarantee the correctness of the information displayed.
M/C Summaries
- 2 summaries submitted
- 2 summaries processed
The derived no- or minimum effect level (DN(M)EL) is the level of exposure above which a human should not be exposed to a substance. Please note that when more than one summary is provided, DN(M)EL values may refer to constituents of the substance and not to the substance as a whole. More detailed information is available in the dossiers.
Data for WORKERS
| INHALATION Exposure | Threshold | Most sensitive study |
|---|---|---|
| Systemic Effects | ||
| Long-term: | (DNEL) 5.61 mg/m³ | repeated dose toxicity |
| Acute /short term: | No hazard identified | |
| Local Effects | ||
| Long-term: | Medium hazard (no threshold derived) | |
| Acute /short term: | Medium hazard (no threshold derived) | |
| DERMAL Exposure | Threshold | Most sensitive study |
| Systemic Effects | ||
| Long-term: | (DNEL) 1.59 mg/kg bw/day | repeated dose toxicity |
| Acute /short term: | No hazard identified | |
| Local Effects | ||
| Long-term: | Medium hazard (no threshold derived) | |
| Acute /short term: | Medium hazard (no threshold derived) | |
| EYE Exposure | ||
| Medium hazard (no threshold derived) | ||
Data for the GENERAL POPULATION
| INHALATION Exposure | Threshold | Most sensitive study |
|---|---|---|
| Systemic Effects | ||
| Long-term: | (DNEL) 1.38 mg/m³ | repeated dose toxicity |
| Acute /short term: | No hazard identified | |
| Local Effects | ||
| Long-term: | Medium hazard (no threshold derived) | |
| Acute /short term: | Medium hazard (no threshold derived) | |
| DERMAL Exposure | Threshold | Most sensitive study |
| Systemic Effects | ||
| Long-term: | (DNEL) 800 µg/kg bw/day | repeated dose toxicity |
| Acute /short term: | No hazard identified | |
| Local Effects | ||
| Long-term: | Medium hazard (no threshold derived) | |
| Acute /short term: | Medium hazard (no threshold derived) | |
| ORAL Exposure | Threshold | Most sensitive study |
| Systemic Effects | ||
| Long-term: | (DNEL) 800 µg/kg bw/day | repeated dose toxicity |
| Acute /short term: | No hazard identified | |
| EYE Exposure | ||
| Medium hazard (no threshold derived) | ||
Study results
Study data: basic toxicokinetics
- 6 studies submitted
- 0 studies processed
Study data not processed for brief profile
Type of Study provided
Study data: basic toxicokinetics
| Studies with data | ||||
|---|---|---|---|---|
| Key study | 2 | |||
| Supporting study | 2 | |||
| Weight of evidence | ||||
| Other | 2 |
| Data waiving | |
|---|---|
| no waivers | |
Study data: dermal absorption
- 0 studies submitted
- 0 studies processed
Study data not processed for brief profile
Study data: dermal absorption
| Studies with data | ||||
|---|---|---|---|---|
| Key study | ||||
| Supporting study | ||||
| Weight of evidence | ||||
| Other |
| Data waiving | |
|---|---|
| no waivers | |
Summaries
- 2 summaries submitted
- 0 summaries processed
No automatically processable data submitted
Study results
oral
- 29 studies submitted
- 4 studies processed
- P/RResults
- LD50 3 400 - 5 150 mg/kg bw (rat) [4]
Type of Study provided
oral
| Studies with data | ||||
|---|---|---|---|---|
| Key study | 4 | |||
| Supporting study | ||||
| Weight of evidence | ||||
| Other | 24 | 1 |
| Data waiving | |
|---|---|
| no waivers | |
inhalation
- 3 studies submitted
- 2 studies processed
- P/RResults
- LC50 (4 h) 2.06 mg/L air (rat) [2]
inhalation
| Studies with data | ||||
|---|---|---|---|---|
| Key study | 1 | 1 | 1 | |
| Supporting study | ||||
| Weight of evidence | ||||
| Other |
| Data waiving | |
|---|---|
| no waivers | |
dermal
- 3 studies submitted
- 2 studies processed
- P/RResults
- LD50 5 000 mg/kg bw (rat) [2]
dermal
| Studies with data | ||||
|---|---|---|---|---|
| Key study | 1 | 1 | 1 | |
| Supporting study | ||||
| Weight of evidence | ||||
| Other |
| Data waiving | |
|---|---|
| no waivers | |
other routes
- 0 studies submitted
- 0 studies processed
No data available
other routes
| Studies with data | ||||
|---|---|---|---|---|
| Key study | ||||
| Supporting study | ||||
| Weight of evidence | ||||
| Other |
| Data waiving | |
|---|---|
| no waivers | |
Summaries
- 2 summaries submitted
- 0 summaries processed
No automatically processable data submitted
Study results
Study data: skin
- 66 studies submitted
- 0 studies processed
Study data not processed for brief profile
Type of Study provided
Study data: skin
| Studies with data | ||||
|---|---|---|---|---|
| Key study | 6 | |||
| Supporting study | 8 | |||
| Weight of evidence | ||||
| Other | 50 | 1 |
| Data waiving | |
|---|---|
| Not feasible | |
| Sci. unjustified | 1 |
| Exposure cons. | |
| Other |
Study data: eye
- 37 studies submitted
- 0 studies processed
Study data not processed for brief profile
Study data: eye
| Studies with data | ||||
|---|---|---|---|---|
| Key study | ||||
| Supporting study | ||||
| Weight of evidence | 10 | |||
| Other | 24 | 1 |
| Data waiving | |
|---|---|
| Not feasible | |
| Sci. unjustified | |
| Exposure cons. | |
| Other | 2 |
Summaries
- 2 summaries submitted
- 0 summaries processed
No automatically processable data submitted
Study results
Study data: skin
- 4 studies submitted
- 0 studies processed
Study data not processed for brief profile
Type of Study provided
Study data: skin
| Studies with data | ||||
|---|---|---|---|---|
| Key study | 1 | 1 | 1 | |
| Supporting study | ||||
| Weight of evidence | ||||
| Other |
| Data waiving | |
|---|---|
| Not feasible | |
| Sci. unjustified | 1 |
| Exposure cons. | |
| Other |
Study data: respiratory
- 0 studies submitted
- 0 studies processed
Study data not processed for brief profile
Study data: respiratory
| Studies with data | ||||
|---|---|---|---|---|
| Key study | ||||
| Supporting study | ||||
| Weight of evidence | ||||
| Other |
| Data waiving | |
|---|---|
| no waivers | |
Summaries
- 2 summaries submitted
- 0 summaries processed
No automatically processable data submitted
Study results
Study data: oral
- 6 studies submitted
- 4 studies processed
- P/RResults
- NOAEL (rat): 159 - 2 400 mg/kg bw/day [4]
Type of Study provided
Study data: oral
| Studies with data | ||||
|---|---|---|---|---|
| Key study | 4 | |||
| Supporting study | 2 | |||
| Weight of evidence | ||||
| Other |
| Data waiving | |
|---|---|
| no waivers | |
Study data: inhalation
- 2 studies submitted
- 0 studies processed
No automatically processable data submitted
Study data: inhalation
| Studies with data | ||||
|---|---|---|---|---|
| Key study | ||||
| Supporting study | ||||
| Weight of evidence | ||||
| Other |
| Data waiving | |
|---|---|
| Not feasible | |
| Sci. unjustified | |
| Exposure cons. | |
| Other | 2 |
Study data: dermal
- 2 studies submitted
- 0 studies processed
No automatically processable data submitted
Study data: dermal
| Studies with data | ||||
|---|---|---|---|---|
| Key study | ||||
| Supporting study | ||||
| Weight of evidence | ||||
| Other |
| Data waiving | |
|---|---|
| Not feasible | |
| Sci. unjustified | |
| Exposure cons. | |
| Other | 2 |
Summaries
- 2 summaries submitted
- 0 summaries processed
No automatically processable data submitted
Study results
Study data: in vitro
- 13 studies submitted
- 0 studies processed
Study data not processed for brief profile
Type of Study provided
Study data: in vitro
| Studies with data | ||||
|---|---|---|---|---|
| Key study | 5 | 1 | ||
| Supporting study | ||||
| Weight of evidence | 4 | 1 | 2 | |
| Other |
| Data waiving | |
|---|---|
| no waivers | |
Study data: in vivo
- 2 studies submitted
- 0 studies processed
Study data not processed for brief profile
Study data: in vivo
| Studies with data | ||||
|---|---|---|---|---|
| Key study | 2 | |||
| Supporting study | ||||
| Weight of evidence | ||||
| Other |
| Data waiving | |
|---|---|
| no waivers | |
Summaries
- 2 summaries submitted
- 0 summaries processed
No automatically processable data submitted
Study results
- 0 studies submitted
- 0 studies processed
Study data not processed for brief profile
Type of Study provided
| Studies with data | ||||
|---|---|---|---|---|
| Key study | ||||
| Supporting study | ||||
| Weight of evidence | ||||
| Other |
| Data waiving | |
|---|---|
| no waivers | |
Summaries
- 2 summaries submitted
- 0 summaries processed
No automatically processable data submitted
Study results
Study data: reproduction
- 2 studies submitted
- 0 studies processed
Study data not processed for brief profile
Type of Study provided
Study data: reproduction
| Studies with data | ||||
|---|---|---|---|---|
| Key study | 2 | |||
| Supporting study | ||||
| Weight of evidence | ||||
| Other |
| Data waiving | |
|---|---|
| no waivers | |
Study data: developmental
- 4 studies submitted
- 0 studies processed
Study data not processed for brief profile
Study data: developmental
| Studies with data | ||||
|---|---|---|---|---|
| Key study | 1 | 1 | 1 | |
| Supporting study | ||||
| Weight of evidence | ||||
| Other |
| Data waiving | |
|---|---|
| Not feasible | |
| Sci. unjustified | 1 |
| Exposure cons. | |
| Other |
Study data: other studies
- 6 studies submitted
- 0 studies processed
Study data not processed for brief profile
Study data: other studies
| Studies with data | ||||
|---|---|---|---|---|
| Key study | 5 | 1 | ||
| Supporting study | ||||
| Weight of evidence | ||||
| Other |
| Data waiving | |
|---|---|
| no waivers | |
Summaries
- 2 summaries submitted
- 0 summaries processed
No automatically processable data submitted
The brief profile is based on non-confidential data contained in ECHA’s databases at the time of generation. Please be aware that as additional data is submitted to ECHA, the brief profile will also be updated to reflect the new situation. All data remain the property of its respective owners.
Note that the brief profile is an automatically generated summary and that not all available data may be displayed. The content is subject to change without prior notice. The information has not been reviewed or verified by ECHA or any other authority. The Agency thus cannot guarantee the correctness of the information displayed. The identification of applicable legislative frameworks is done automatically and without manual verification. Therefore this does not constitute official and legally binding information. To confirm if a substance is covered by a specific legislative framework the official publication should be consulted.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner. The Agency does not take any responsibility whatsoever for any copyright or other infringements that may be caused by using the information. This brief profile is covered by the ECHA Legal Notice.
